Caplacizumab

( DrugBank: Caplacizumab / KEGG DRUG: Caplacizumab )


2 diseases
IDDisease name (Link within this page)Number of trials
63Idiopathic thrombocytopenic purpura1
IDDisease name (Link within this page)Number of trials
64Thrombotic thrombocytopenic purpura42

63. Idiopathic thrombocytopenic purpura


Clinical trials : 575Drugs : 261 - (DrugBank : 64) / Drug target genes : 61 - Drug target pathways : 142 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

64. Thrombotic thrombocytopenic purpura


Clinical trials : 109Drugs : 67 - (DrugBank : 17) / Drug target genes : 18 - Drug target pathways : 75 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries